Out-of-pocket costs analysis of ifosfamide, epirubicin, and etoposide (IEV) and etoposide, solu-medrol-methylprednisolone, high-dose ara-C-cytarabine, and platinol-cisplatin (ESHAP) regimens in the patients with relapsed and refractory lymphoma in Iran
BACKGROUND: This is an out-of-pocket costs analysis of ifosfamide, epirubicin, and etoposide (IEV) and etoposide, solu-medrol-methylprednisolone, high-dose ara-C-cytarabine, and platinol-cisplatin (ESHAP) drug regimens in treatment of lymphoma in Iran. METHODS: This cross-sectional study was cond...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Vesnu Publications
2019-07-01
|
| Series: | Chronic Diseases Journal |
| Subjects: | |
| Online Access: | http://cdjournal.muk.ac.ir/index.php/cdj/article/view/270 |